Product Information
MIRTAZAPINE 15 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0630 per EA under NDC 00378351593. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 19, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378351593
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MIRTAZAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA076122FDA Approved
6/19/2003
TE Code
AB
On Market Since
6/20/2003
Price Statistics
The NADAC for MIRTAZAPINE 15 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 39.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0630 per EA |
|---|---|
| All-time high | $0.2016 (Aug 13, 2014) |
| All-time low | $0.0546 (Nov 20, 2024) |
| 52-week high | $0.0723 |
| 52-week low | $0.0630 |
| Median price | $0.0827 |
| Average price | $0.0919 |
| Largest weekly change | +48.3% (May 21, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mirtazapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIRTAZAPINE 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MIRTAZAPINE 15 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0630 per EA (NDC 00378351593), effective Sep 30, 2026.
How has the price of MIRTAZAPINE 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for MIRTAZAPINE 15 MG TABLET has declined 39.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MIRTAZAPINE 15 MG TABLET?
Since Nov 28, 2013, the NADAC for MIRTAZAPINE 15 MG TABLET has ranged from a low of $0.0546 (Nov 20, 2024) to a high of $0.2016 (Aug 13, 2014), with a median of $0.0827 per EA.
Are there cheaper alternatives to MIRTAZAPINE 15 MG TABLET?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MIRTAZAPINE 15 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MIRTAZAPINE 15 MG TABLET?
MIRTAZAPINE 15 MG TABLET (NDC 00378351593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.